|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 218 for Cx3cl1

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.065s

Categories

Category: Publication
Type Details Score
Publication
First Author: Hundhausen C
Year: 2003
Journal: Blood
Title: The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.
Volume: 102
Issue: 4
Pages: 1186-95
Publication
First Author: Tardáguila M
Year: 2013
Journal: Cancer Res
Title: CX3CL1 promotes breast cancer via transactivation of the EGF pathway.
Volume: 73
Issue: 14
Pages: 4461-73
Publication
First Author: Cipriani R
Year: 2011
Journal: J Neurosci
Title: CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents.
Volume: 31
Issue: 45
Pages: 16327-35
Publication
First Author: Gevrey JC
Year: 2005
Journal: J Immunol
Title: Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine).
Volume: 175
Issue: 6
Pages: 3737-45
Publication
First Author: Winter AN
Year: 2020
Journal: J Neuroinflammation
Title: Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice.
Volume: 17
Issue: 1
Pages: 157
Publication
First Author: Zieger M
Year: 2014
Journal: PLoS One
Title: CX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies.
Volume: 9
Issue: 9
Pages: e106562
Publication
First Author: Suzuki F
Year: 2005
Journal: J Immunol
Title: Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice.
Volume: 175
Issue: 10
Pages: 6987-96
Publication
First Author: Fan Q
Year: 2019
Journal: J Exp Med
Title: The intracellular domain of CX3CL1 regulates adult neurogenesis and Alzheimer's amyloid pathology.
Volume: 216
Issue: 8
Pages: 1891-1903
Publication
First Author: Morganti JM
Year: 2012
Journal: J Neurosci
Title: The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease.
Volume: 32
Issue: 42
Pages: 14592-601
Publication
First Author: Johnson LA
Year: 2013
Journal: J Cell Sci
Title: The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics.
Volume: 126
Issue: Pt 22
Pages: 5259-70
Publication
First Author: Gayen M
Year: 2022
Journal: J Biol Chem
Title: The CX3CL1 intracellular domain exhibits neuroprotection via insulin receptor/insulin-like growth factor receptor signaling.
Volume: 298
Issue: 11
Pages: 102532
Publication
First Author: Morimura S
Year: 2013
Journal: Am J Pathol
Title: Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition.
Volume: 182
Issue: 5
Pages: 1640-7
Publication
First Author: Lee S
Year: 2014
Journal: J Neurosci
Title: Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway.
Volume: 34
Issue: 37
Pages: 12538-46
Publication
First Author: Pallandre JR
Year: 2008
Journal: Blood
Title: Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation.
Volume: 112
Issue: 12
Pages: 4420-4
Publication
First Author: Goto Y
Year: 2016
Journal: Stem Cells
Title: CXCR4+ CD45- Cells are Niche Forming for Osteoclastogenesis via the SDF-1, CXCL7, and CX3CL1 Signaling Pathways in Bone Marrow.
Volume: 34
Issue: 11
Pages: 2733-2743
Publication
First Author: Corcione A
Year: 2009
Journal: PLoS One
Title: CX3CR1 is expressed by human B lymphocytes and mediates [corrected] CX3CL1 driven chemotaxis of tonsil centrocytes.
Volume: 4
Issue: 12
Pages: e8485
Publication
First Author: McComb JG
Year: 2008
Journal: Am J Pathol
Title: CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema.
Volume: 173
Issue: 4
Pages: 949-61
Publication
First Author: Ludwig A
Year: 2007
Journal: Thromb Haemost
Title: Transmembrane chemokines: versatile 'special agents' in vascular inflammation.
Volume: 97
Issue: 5
Pages: 694-703
Publication
First Author: Garton KJ
Year: 2001
Journal: J Biol Chem
Title: Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).
Volume: 276
Issue: 41
Pages: 37993-8001
Publication
First Author: Fujita M
Year: 2014
Journal: PLoS One
Title: The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Volume: 9
Issue: 5
Pages: e96372
Publication
First Author: Umehara H
Year: 2004
Journal: Arterioscler Thromb Vasc Biol
Title: Fractalkine in vascular biology: from basic research to clinical disease.
Volume: 24
Issue: 1
Pages: 34-40
Publication
First Author: Imai T
Year: 1997
Journal: Cell
Title: Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.
Volume: 91
Issue: 4
Pages: 521-30
Publication
First Author: Bazan JF
Year: 1997
Journal: Nature
Title: A new class of membrane-bound chemokine with a CX3C motif.
Volume: 385
Issue: 6617
Pages: 640-4
Publication
First Author: Ancuta P
Year: 2003
Journal: J Exp Med
Title: Fractalkine preferentially mediates arrest and migration of CD16+ monocytes.
Volume: 197
Issue: 12
Pages: 1701-7
Publication
First Author: Ma Q
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.
Volume: 95
Issue: 16
Pages: 9448-53
Publication
First Author: Horuk R
Year: 2001
Journal: Cytokine Growth Factor Rev
Title: Chemokine receptors.
Volume: 12
Issue: 4
Pages: 313-35
Publication
First Author: Charbonnier AS
Year: 1999
Journal: J Exp Med
Title: Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells.
Volume: 190
Issue: 12
Pages: 1755-68
Publication
First Author: Sallusto F
Year: 1998
Journal: J Exp Med
Title: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.
Volume: 187
Issue: 6
Pages: 875-83
Publication
First Author: Strieter RM
Year: 1995
Journal: J Biol Chem
Title: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.
Volume: 270
Issue: 45
Pages: 27348-57
Publication
First Author: Zlotnik A
Year: 2000
Journal: Immunity
Title: Chemokines: a new classification system and their role in immunity.
Volume: 12
Issue: 2
Pages: 121-7
Publication
First Author: Bemiller SM
Year: 2018
Journal: J Neuroinflammation
Title: Genetically enhancing the expression of chemokine domain of CX3CL1 fails to prevent tau pathology in mouse models of tauopathy.
Volume: 15
Issue: 1
Pages: 278
Publication
First Author: Jobling AI
Year: 2018
Journal: J Neurosci
Title: The Role of the Microglial Cx3cr1 Pathway in the Postnatal Maturation of Retinal Photoreceptors.
Volume: 38
Issue: 20
Pages: 4708-4723
Publication      
First Author: Godwin MS
Year: 2020
Journal: Am J Physiol Lung Cell Mol Physiol
Title: The chemokine CX3CL1/fractalkine regulates immunopathogenesis during fungal-associated allergic airway inflammation.
Publication
First Author: Mizoguchi M
Year: 2018
Journal: PLoS One
Title: Prevention of lipopolysaccharide-induced preterm labor by the lack of CX3CL1-CX3CR1 interaction in mice.
Volume: 13
Issue: 11
Pages: e0207085
Publication
First Author: Cunha C
Year: 2018
Journal: Mol Neurobiol
Title: Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage.
Volume: 55
Issue: 5
Pages: 4207-4224
Publication
First Author: Zhang Y
Year: 2018
Journal: Sci Adv
Title: Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation.
Volume: 4
Issue: 3
Pages: eaap8492
Publication
First Author: Kim KW
Year: 2011
Journal: Blood
Title: In vivo structure/function and expression analysis of the CX3C chemokine fractalkine.
Volume: 118
Issue: 22
Pages: e156-67
Publication
First Author: Gunner G
Year: 2019
Journal: Nat Neurosci
Title: Sensory lesioning induces microglial synapse elimination via ADAM10 and fractalkine signaling.
Volume: 22
Issue: 7
Pages: 1075-1088
Publication  
First Author: Grizenkova J
Year: 2014
Journal: BMC Neurosci
Title: Microglial Cx3cr1 knockout reduces prion disease incubation time in mice.
Volume: 15
Pages: 44
Publication
First Author: Mikosz A
Year: 2023
Journal: Am J Physiol Lung Cell Mol Physiol
Title: Alpha-1 antitrypsin inhibits fractalkine-mediated monocyte-lung endothelial cell interactions.
Volume: 325
Issue: 6
Pages: L711-L725
Publication
First Author: Hoshiko M
Year: 2012
Journal: J Neurosci
Title: Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex.
Volume: 32
Issue: 43
Pages: 15106-11
Publication
First Author: Staumont-Sallé D
Year: 2014
Journal: J Exp Med
Title: CX₃CL1 (fractalkine) and its receptor CX₃CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin.
Volume: 211
Issue: 6
Pages: 1185-96
Publication
First Author: Yu YR
Year: 2007
Journal: Int J Cancer
Title: Defective antitumor responses in CX3CR1-deficient mice.
Volume: 121
Issue: 2
Pages: 316-22
Publication
First Author: Bian C
Year: 2015
Journal: PLoS One
Title: Involvement of CX3CL1/CX3CR1 signaling in spinal long term potentiation.
Volume: 10
Issue: 3
Pages: e0118842
Publication
First Author: Koizumi K
Year: 2009
Journal: J Immunol
Title: Role of CX3CL1/fractalkine in osteoclast differentiation and bone resorption.
Volume: 183
Issue: 12
Pages: 7825-31
Publication
First Author: Fan Q
Year: 2020
Journal: J Neurosci
Title: Activated CX3CL1/Smad2 Signals Prevent Neuronal Loss and Alzheimer's Tau Pathology-Mediated Cognitive Dysfunction.
Volume: 40
Issue: 5
Pages: 1133-1144
Publication  
First Author: Nagashimada M
Year: 2021
Journal: Endocrinology
Title: CX3CL1-CX3CR1 Signaling Deficiency Exacerbates Obesity-induced Inflammation and Insulin Resistance in Male Mice.
Volume: 162
Issue: 6
Publication
First Author: Huang D
Year: 2006
Journal: FASEB J
Title: The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system.
Volume: 20
Issue: 7
Pages: 896-905
Publication
First Author: Seo Y
Year: 2016
Journal: Glia
Title: Cathepsin S contributes to microglia-mediated olfactory dysfunction through the regulation of Cx3cl1-Cx3cr1 axis in a Niemann-Pick disease type C1 model.
Volume: 64
Issue: 12
Pages: 2291-2305
Publication
First Author: Lu P
Year: 2008
Journal: J Immunol
Title: Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression.
Volume: 180
Issue: 6
Pages: 4283-91
Publication
First Author: Zabel MK
Year: 2016
Journal: Glia
Title: Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1-CX3CR1 signaling in a mouse model of retinitis pigmentosa.
Volume: 64
Issue: 9
Pages: 1479-91
Publication
First Author: Green SR
Year: 2006
Journal: J Immunol
Title: The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
Volume: 176
Issue: 12
Pages: 7412-20
Publication  
First Author: Ni Y
Year: 2022
Journal: Metabolism
Title: CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status.
Volume: 136
Pages: 155272
Publication
First Author: Thome AD
Year: 2015
Journal: PLoS One
Title: Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.
Volume: 10
Issue: 10
Pages: e0140566
Publication  
First Author: Montagud-Romero S
Year: 2020
Journal: Prog Neuropsychopharmacol Biol Psychiatry
Title: Social defeat-induced increase in the conditioned rewarding effects of cocaine: Role of CX3CL1.
Volume: 96
Pages: 109753
Publication
First Author: Saederup N
Year: 2008
Journal: Circulation
Title: Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis.
Volume: 117
Issue: 13
Pages: 1642-8
Publication
First Author: Wang Y
Year: 2016
Journal: Biochem Biophys Res Commun
Title: Icariin inhibits atherosclerosis progress in Apoe null mice by downregulating CX3CR1 in macrophage.
Volume: 470
Issue: 4
Pages: 845-50
Publication
First Author: Amsellem V
Year: 2017
Journal: Am J Respir Cell Mol Biol
Title: Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
Volume: 56
Issue: 5
Pages: 597-608
Publication
First Author: Ishida Y
Year: 2008
Journal: J Immunol
Title: Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function.
Volume: 180
Issue: 1
Pages: 569-79
Publication
First Author: Martínez-Hervás S
Year: 2014
Journal: Cardiovasc Res
Title: Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
Volume: 103
Issue: 2
Pages: 324-36
Publication
First Author: Zhang D
Year: 2006
Journal: J Neurochem
Title: Identification of potential target genes for RFX4_v3, a transcription factor critical for brain development.
Volume: 98
Issue: 3
Pages: 860-75
Publication
First Author: Pan Y
Year: 1997
Journal: Nature
Title: Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.
Volume: 387
Issue: 6633
Pages: 611-7
Publication
First Author: Cook DN
Year: 2001
Journal: Mol Cell Biol
Title: Generation and analysis of mice lacking the chemokine fractalkine.
Volume: 21
Issue: 9
Pages: 3159-65
Publication
First Author: Soriano SG
Year: 2002
Journal: J Neuroimmunol
Title: Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury.
Volume: 125
Issue: 1-2
Pages: 59-65
Publication
First Author: Ren T
Year: 2007
Journal: Biochem Biophys Res Commun
Title: Down-regulation of surface fractalkine by RNA interference in B16 melanoma reduced tumor growth in mice.
Volume: 364
Issue: 4
Pages: 978-84
Publication
First Author: Tarozzo G
Year: 2003
Journal: J Neurosci Res
Title: Fractalkine protein localization and gene expression in mouse brain.
Volume: 73
Issue: 1
Pages: 81-8
Publication
First Author: Kanazawa N
Year: 1999
Journal: Eur J Immunol
Title: Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells.
Volume: 29
Issue: 6
Pages: 1925-32
Publication
First Author: Hiroyama T
Year: 2001
Journal: Genomics
Title: Fractalkine shares signal sequence with TARC: gene structures and expression profiles of two chemokine genes.
Volume: 75
Issue: 1-3
Pages: 3-5
Publication
First Author: Ueha S
Year: 2007
Journal: J Leukoc Biol
Title: Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
Volume: 81
Issue: 1
Pages: 176-85
Publication
First Author: Cardona AE
Year: 2006
Journal: Nat Neurosci
Title: Control of microglial neurotoxicity by the fractalkine receptor.
Volume: 9
Issue: 7
Pages: 917-24
Publication
First Author: Rius C
Year: 2013
Journal: Arterioscler Thromb Vasc Biol
Title: Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II.
Volume: 33
Issue: 1
Pages: 96-104
Publication
First Author: Müller I
Year: 2017
Journal: PLoS One
Title: CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.
Volume: 12
Issue: 8
Pages: e0182643
Publication  
First Author: Liu Y
Year: 2020
Journal: Behav Brain Res
Title: Involvement of CX3CL1/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism.
Volume: 381
Pages: 112371
Publication  
First Author: Suzuki M
Year: 2011
Journal: Mol Neurodegener
Title: Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death.
Volume: 6
Pages: 78
Publication
First Author: Truman LA
Year: 2008
Journal: Blood
Title: CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis.
Volume: 112
Issue: 13
Pages: 5026-36
Publication  
First Author: Fu D
Year: 2019
Journal: Front Immunol
Title: FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis.
Volume: 10
Pages: 784
Publication
First Author: Taube D
Year: 2013
Journal: PLoS One
Title: Fractalkine depresses cardiomyocyte contractility.
Volume: 8
Issue: 7
Pages: e69832
Publication
First Author: Fuster-Matanzo A
Year: 2017
Journal: Cell Mol Life Sci
Title: Glycogen synthase kinase-3β regulates fractalkine production by altering its trafficking from Golgi to plasma membrane: implications for Alzheimer's disease.
Volume: 74
Issue: 6
Pages: 1153-1163
Publication
First Author: Vukovic J
Year: 2012
Journal: J Neurosci
Title: Microglia modulate hippocampal neural precursor activity in response to exercise and aging.
Volume: 32
Issue: 19
Pages: 6435-43
Publication  
First Author: Mendiola AS
Year: 2016
Journal: Front Cell Neurosci
Title: Fractalkine Signaling Attenuates Perivascular Clustering of Microglia and Fibrinogen Leakage during Systemic Inflammation in Mouse Models of Diabetic Retinopathy.
Volume: 10
Pages: 303
Publication
First Author: Ma B
Year: 2016
Journal: Hum Mol Genet
Title: LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways.
Volume: 25
Issue: 16
Pages: 3515-3523
Publication
First Author: Lauro C
Year: 2008
Journal: J Immunol
Title: Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons.
Volume: 180
Issue: 11
Pages: 7590-6
Publication
First Author: Kostadinova FI
Year: 2010
Journal: J Leukoc Biol
Title: Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in mice.
Volume: 88
Issue: 1
Pages: 133-43
Publication
First Author: Inui M
Year: 2011
Journal: J Immunol
Title: Protective roles of CX3CR1-mediated signals in toxin A-induced enteritis through the induction of heme oxygenase-1 expression.
Volume: 186
Issue: 1
Pages: 423-31
Publication
First Author: Kikuchi T
Year: 2005
Journal: Infect Immun
Title: Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.
Volume: 73
Issue: 9
Pages: 5350-7
Publication
First Author: Song B
Year: 2013
Journal: Circ J
Title: Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway.
Volume: 77
Issue: 12
Pages: 2997-3006
Publication
First Author: Lesnik P
Year: 2003
Journal: J Clin Invest
Title: Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.
Volume: 111
Issue: 3
Pages: 333-40
Publication
First Author: Morita N
Year: 2019
Journal: Nature
Title: GPR31-dependent dendrite protrusion of intestinal CX3CR1+ cells by bacterial metabolites.
Volume: 566
Issue: 7742
Pages: 110-114
Publication
First Author: Landsman L
Year: 2009
Journal: Blood
Title: CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.
Volume: 113
Issue: 4
Pages: 963-72
Publication
First Author: Teupser D
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.
Volume: 101
Issue: 51
Pages: 17795-800
Publication
First Author: Stolla M
Year: 2012
Journal: PLoS One
Title: Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
Volume: 7
Issue: 8
Pages: e43572
Publication
First Author: Bosse A
Year: 2000
Journal: Dev Dyn
Title: Identification of a novel mouse Iroquois homeobox gene, Irx5, and chromosomal localisation of all members of the mouse Iroquois gene family.
Volume: 218
Issue: 1
Pages: 160-74
Publication
First Author: Rossi DL
Year: 1998
Journal: Genomics
Title: Cloning and characterization of a new type of mouse chemokine.
Volume: 47
Issue: 2
Pages: 163-70
Publication
First Author: Codner GF
Year: 2018
Journal: BMC Biol
Title: Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants.
Volume: 16
Issue: 1
Pages: 70
Publication
First Author: Ondondo B
Year: 2015
Journal: Immunology
Title: A distinct chemokine axis does not account for enrichment of Foxp3(+)  CD4(+) T cells in carcinogen-induced fibrosarcomas.
Volume: 145
Issue: 1
Pages: 94-104
Publication
First Author: Tsuji D
Year: 2005
Journal: J Neurochem
Title: Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
Volume: 92
Issue: 6
Pages: 1497-507
Publication
First Author: Katakai T
Year: 2004
Journal: J Exp Med
Title: Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes.
Volume: 200
Issue: 6
Pages: 783-95
Publication  
First Author: Chen HJ
Year: 2024
Journal: Brain Behav Immun
Title: Fetal CCL2 signaling mediates offspring social behavior and recapitulates effects of prenatal stress.
Volume: 115
Pages: 308-318
Publication
First Author: Inoue S
Year: 2000
Journal: Biochem Biophys Res Commun
Title: Growth suppression of Escherichia coli by induction of expression of mammalian genes with transmembrane or ATPase domains.
Volume: 268
Issue: 2
Pages: 553-61
Publication
First Author: Nishinakamura R
Year: 2001
Journal: Development
Title: Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development.
Volume: 128
Issue: 16
Pages: 3105-15